Manzanita Pharmaceuticals
ApprovedThe Manzanita Pharmaceuticals, Inc. core technology is attaching generic, small molecules dyes or drugs to the human forms (recombinant human) of the neurotrophins Nerve Growth Factor (rhNGF) and/or brain-derived neurotrophic factor (rhBDNF). The first product application is a nerve imaging agent: a commercial, generic, small molecule dye in the 800 nanometer region (Near InfraRed, NIR) attached to human NGF (800-rhNGF).
About
The Manzanita Pharmaceuticals, Inc. core technology is attaching generic, small molecules dyes or drugs to the human forms (recombinant human) of the neurotrophins Nerve Growth Factor (rhNGF) and/or brain-derived neurotrophic factor (rhBDNF). The first product application is a nerve imaging agent: a commercial, generic, small molecule dye in the 800 nanometer region (Near InfraRed, NIR) attached to human NGF (800-rhNGF).
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile